Xarelto副作用

Rivaroxaban (Xarelto, Xarelto) was jointly developed by Bayer and Johnson & Johnson. Rivaroxaban (Xarelto, Xarelto) is a highly selective oral drug that directly inhibits factor xa. It inhibits FXa and inhibits the intrinsic and extrinsic coagulation pathways in a dose-dependent manner to inhibit thrombosis. Rivaroxaban (Xarelto) is approved for the prevention of venous thrombosis in adult patients undergoing elective hip or knee replacement surgery.

Rivaroxaban (Xarelto, Xarelto) side effects: Common side effects of rivaroxaban (Xarelto, Xarelto) include: bleeding. The possibility of bleeding should be considered when symptoms such as weakness, weakness, paleness, dizziness, headache, or unexplained swelling occur after taking the drug. Bleeding from other parts includes: postoperative wound bleeding, postoperative anemia, muscle bleeding, gum bleeding, hemoptysis, hematochezia, hematemesis, menorrhagia, epistaxis, conjunctival hemorrhage, cerebral hemorrhage, etc. Other rare side effects include: abnormal liver function indicators, such as increased serum gamma-glutamyl transferase, aminotransferase, lactate dehydrogenase, etc. Tachycardia. Symptoms of anemia include pale complexion, weakness, and weakness. Nervous system manifestations of syncope (including loss of consciousness, dizziness, headache). Nausea, constipation, diarrhea, abdominal pain, indigestion, dry mouth, vomiting and other digestive system manifestations. Skin symptoms such as itching, rash, and urticaria appear. Edema, fever, and allergic dermatitis may occur throughout the body or at the administration site. Rivaroxaban (Xarelto) contains lactose and should not be taken by patients with rare hereditary galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. There are no studies on the effects of rivaroxaban (Xarelto) on the ability to drive and use machinery. There have been reports of syncope and dizziness after surgery, which may affect the ability to drive and use machinery. The report states that these adverse reactions are uncommon. Patients experiencing these adverse reactions should not drive or use machinery.